ARCHIVES

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

Mammary Cell/Hormone Report Abstracts From BCTF Meeting

January 16, 1976

Lederle Scientists Report Powerful New Anticancer Agent

July 31, 1987

M.D. Anderson Sells Itself As Research Base For CCOPs

August 8, 1986

Columbia Receives $1 Million ACS Grants

May 3, 1985

Bypass Budget Seeks Double Funding for Breast Cancer Research

November 6, 1992

HER2+ Tumors Increase Risk Of Recurrence, Study Finds

November 27, 2009